Cover Image

Aggressive Fibromatosis with Bone Involvement- A Case Report

RAJA KS KSELVAM

Abstract


Aggressive fibromatosis is a condition marked by the presence of desmoids tumours, which are benign,              slow-growing musculo-aponeurotic tumours with no evidence of any metastatic potential6. It is known to involve muscle, subcutaneous tissue and neurovascular structures. However, bone involvement is very rare1. We have presented the case report of a 13 year old boy with aggressive fibromatosis in the left gluteal region involving the supra acetabular portion of ilium and a part of ischium. Clinical examination revealed a firm swelling about 6x5x1 centimetres in the upper outer quadrant of left gluteal region. Complete blood count and ESR were normal. X-ray pelvis with both hips revealed an osteolytic lesion in the supra acetabular portion of left ilium. Computed Tomography showed geographic, lytic lesions involving the supra acetabular region of left ilium, quadrilateral plate and a part of ischium. MRI showed a soft tissue mass adjacent to the left ilium, infiltrating in to supra acetabular region of left ilium, and a part of ischium. With these findings our differential diagnoses were chronic osteomyelitis,             eosinophlic granuloma and cystic type of fibrous dysplsia. CT scan guided FNAC showed degenerated osteocytes with occasional osteoclastic giant cells and inflammatory               mononuclear cells. Then we did a wide local excision of the tumour with curettage of the surrounding bone.                   Histopathological examination of the specimen was                  suggestive of aggressive fibromatosis. Considering the          hypercellularity and local aggressive behaviour of the tumour we diagnosed it as aggressive fibromatosis. In our two years of follow up the patient did not show any signs of recurrence. This case is being reported for its rarity since fibromatosis involving the bone is an unusual event.

 


Full Text:

PDF

References


Tan V': Low CK, Chong PY. A case report on aggressive fibromatosis with bone involvement Singapore Med J 999; 40(2): It 1-2.

DaJUl J. Jonson N. Lundh G. Desmoid tumours. A series of 33 cases. Ac/ochirllrgico Scondil10l'ico 1963. 126: 305-14.

McAdam WAF. Golgher lC. Tile. Occurrence of desmoids. patients with familial polyposis coli. Br J Surg 1970; 618-31.

Reitano JJ, Scheimin TM. Harry P. The desmoid syndrome. New concepts in the cause. pathogenesis and treatment of desmoid tumour. Am.J SlIrg 1986; 151: 230-37.

Dasgupta TK. Brasfield RD. 0' Hara J. Extra-abdominal desmoids. A c1inico pathological study. An" Surg 1969; t: 109-2t.

Mackenzie DH. The fibromatosis: a clinicopathological concept. Br Med J 1972; 4: 277-8 t.

Posner MC, Shill MH, Newsome IL, Hajdu SI, Gaynor BMF. The desmoid tumour: not a benign disease. Am Surg t989; 124; 19t-6.

Hunt RTN,Morgan HC. and Ackennan LV. Principles in management of extra- abdominal demoids.Cancer 1960; 825-36.

Plukher JT, Vanoort I. Vermey A el 01. Aggressive fibromatosis (non-familial desmoid tumour): therapeutic problems and the role of adjuvant radiotherapy. Br J Surg 995; 82510·514.

Waddell WR, Gerner RE. Indomethacin and ascorbate inhibit desmoid tumours. J Surg Oncol1980; 15: 85–90.

McCollough WM, Parsons JT, van der Griend et al. Radiation therapy for aggressive fibromatosis: the experience at the University of Florida. J Bone Joint Surg1991; 73(A): 717–725.

Sze H, Yeung MW: Fibromatosis of the neck causing airway obstruction managed effectively with weekly low-dose methotrexate and vinblastine. Hong Kong Med J 2009, 15:221–223.

Ilaslan H, Schils J, Joyce M, Marks K, Sundaram M: Radiofrequency ablation: another treatment option for local control of desmoid tumors. Skeletal Radiol 2010, 39: 169–173.

Chugh R, Chugh R, Wathen JK, Patel SR, Maki RG, Meyers PA, Schuetze SM, Priebat DA, Thomas DG, Jacobson JA, Samuels BL, Benjamin RS, Baker LH, Sarcoma Alliance for Research through Collaboration (SARC): Efficacy of imatinib in aggressive fibromatosis: results of a phase II multicenter Sarcoma Alliance for Research through Collaboration (SARC) trial. Clin Cancer Res 2010, 16(19):4884–9481.

Shin SH, KoKR,Cho SK,Choi YL,Seo SW, Surgical outcome of desmoid tumors: adjuvant radiotherapy delayed the recurrence, but did not affect long-term outcomes. J Surg Oncol 2013 Jul;108 (1):28-33.

Matthew T. Ballo, Gunar K. Zagars, Alan Pollack, Peter W.T. Pisters, and Raphael A. Pollock, Desmoid Tumor: Prognostic Factors and Outcome After Surgery, Radiation Therapy, or Combined Surgery and Radiation Therapy. Journal of Clinical Oncology, Vol 17, No 1 (January), 1999: pp 158- 167.

Iris Gluck, Kent A. Griffith, Sybil Biermann, Felix Y. Feng, David R. Lucas, and Edgar Ben- Josef. Role of Radiotherapy In The Management Of Desmoid Tumors. Int. J. Radiation Oncology Biol. Phys., Vol. No.3, pp. 1–6, 2010.

J. Janinis, M. Patriki, L. Vini, G. Aravantinos & J. S. Whelan, The pharmacological treatment of aggressive fibromatosis: A systematic review. Annals of Oncology 14: 181–190, 2003

D. Kotiligam, A.J.F. Lazar, R.E. Pollock and D. Lev. Desmoid tumor: a disease opportune for molecular insights. Histol Histopathol (2008) 23: 117-126 http://www.hh.um.es

Spear MA, Jennings LC, Mankin HJ et al. Individualizing management of aggressive fibromatoses. Int J Radiat Oncol Biol Phys 1998; 40: 637–645.

Wright JG, Swiontkowski MF Heckman JD .Introducing Levels of Evidence to The Journal - Journal Of Bone & Joint Surgery • 85-A • 1 • January 2003.


Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.

An Initiative of The Tamil Nadu Dr MGR Medical University